BAM
AVIR icon

Berkshire Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History

Berkshire Asset Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65,000
Closed -$215K – 282
2024
Q3 		$215K Hold
65,000
– – 0.01% 269
2024
Q2 		$215K Buy
+65,000
New +$215K 0.01% 271